Kurs
-1,82%
Kurs
-1,82%
Open
77,00
High
77,80
Low
74,00
Close
75,60
Kursutveckling under dagen för detta pressmeddelande
(NOK).
Likviditet
8,66 MNOK
Likviditet
8,66 MNOK
Rel. mcap
9,87%
Antal aktier
114 333
Likviditet under dagen för detta pressmeddelande
Kalender
| Tid* | ||
| 2025-02-13 | 07:30 | Bokslutskommuniké 2024 |
| 2025-01-09 | N/A | Extra Bolagsstämma 2025 |
| 2024-11-06 | - | Kvartalsrapport 2024-Q3 |
| 2024-08-21 | - | Kvartalsrapport 2024-Q2 |
| 2024-05-07 | - | Kvartalsrapport 2024-Q1 |
| 2024-04-25 | - | X-dag ordinarie utdelning ULTI 0.00 NOK |
| 2024-04-24 | - | Årsstämma |
| 2024-02-14 | - | Bokslutskommuniké 2023 |
| 2023-11-08 | - | Kvartalsrapport 2023-Q3 |
| 2023-08-22 | - | Kvartalsrapport 2023-Q2 |
| 2023-05-10 | - | Kvartalsrapport 2023-Q1 |
| 2023-04-21 | - | X-dag ordinarie utdelning ULTI 0.00 NOK |
| 2023-04-20 | - | Årsstämma |
| 2023-02-16 | - | Bokslutskommuniké 2022 |
| 2022-11-10 | - | Kvartalsrapport 2022-Q3 |
| 2022-08-19 | - | Kvartalsrapport 2022-Q2 |
| 2022-05-12 | - | Kvartalsrapport 2022-Q1 |
| 2022-04-21 | - | X-dag ordinarie utdelning ULTI 0.00 NOK |
| 2022-04-20 | - | Årsstämma |
| 2022-02-17 | - | Bokslutskommuniké 2021 |
| 2021-11-11 | - | Kvartalsrapport 2021-Q3 |
| 2021-08-20 | - | Kvartalsrapport 2021-Q2 |
| 2021-05-11 | - | Kvartalsrapport 2021-Q1 |
| 2021-04-22 | - | X-dag ordinarie utdelning ULTI 0.00 NOK |
| 2021-04-21 | - | Årsstämma |
| 2021-02-17 | - | Bokslutskommuniké 2020 |
| 2020-11-12 | - | Kvartalsrapport 2020-Q3 |
| 2020-11-11 | - | Extra Bolagsstämma 2020 |
| 2020-08-21 | - | Kvartalsrapport 2020-Q2 |
| 2020-05-14 | - | Kvartalsrapport 2020-Q1 |
| 2020-04-16 | - | X-dag ordinarie utdelning ULTI 0.00 NOK |
| 2020-04-15 | - | Årsstämma |
| 2020-02-14 | - | Bokslutskommuniké 2019 |
| 2019-11-14 | - | Kvartalsrapport 2019-Q3 |
| 2019-08-21 | - | Kvartalsrapport 2019-Q2 |
Beskrivning
| Land | Norge |
|---|---|
| Lista | OB Match |
| Sektor | Hälsovård |
| Industri | Bioteknik |
2021-02-11 12:19:40
Oslo, 11 February, 2021: Primary insiders in Ultimovacs ASA (the 'Company'),
Canica AS and Sundt AS, have today each bought 27,500 shares in the company at a
price of NOK 75.60 per share.
Following this transaction, Canica AS holds 2,535,163 shares in the Company and
Sundt AS holds 719,650 in the Company. Sundt AS together with its two
shareholders CGS Holding AS and Helene Sundt AS hold a total of 2,483,914 shares
in the Company following the transaction.
The total of 55,000 shares were sold by Vitmed AS, a company privately held by
Øyvind Kongstun Arnesen, former CEO of the Company, to finance medical expenses
for close family members of Øyvind Kongstun Arnesen living outside of Norway.
Following this transaction, Vitmed AS holds a total of 105,000 shares in the
Company.
This information is subject to the disclosure requirements pursuant to Section
5-12 the Norwegian Securities Trading Act.